Correlation Between Zura Bio and Molecular Partners
Can any of the company-specific risk be diversified away by investing in both Zura Bio and Molecular Partners at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zura Bio and Molecular Partners into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zura Bio Limited and Molecular Partners AG, you can compare the effects of market volatilities on Zura Bio and Molecular Partners and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zura Bio with a short position of Molecular Partners. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zura Bio and Molecular Partners.
Diversification Opportunities for Zura Bio and Molecular Partners
0.14 | Correlation Coefficient |
Average diversification
The 3 months correlation between Zura and Molecular is 0.14. Overlapping area represents the amount of risk that can be diversified away by holding Zura Bio Limited and Molecular Partners AG in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Molecular Partners and Zura Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zura Bio Limited are associated (or correlated) with Molecular Partners. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Molecular Partners has no effect on the direction of Zura Bio i.e., Zura Bio and Molecular Partners go up and down completely randomly.
Pair Corralation between Zura Bio and Molecular Partners
Given the investment horizon of 90 days Zura Bio Limited is expected to under-perform the Molecular Partners. But the stock apears to be less risky and, when comparing its historical volatility, Zura Bio Limited is 1.16 times less risky than Molecular Partners. The stock trades about -0.35 of its potential returns per unit of risk. The Molecular Partners AG is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 567.00 in Molecular Partners AG on August 24, 2024 and sell it today you would lose (25.00) from holding Molecular Partners AG or give up 4.41% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Zura Bio Limited vs. Molecular Partners AG
Performance |
| Timeline |
| Zura Bio Limited |
| Molecular Partners |
Zura Bio and Molecular Partners Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Zura Bio and Molecular Partners
The main advantage of trading using opposite Zura Bio and Molecular Partners positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zura Bio position performs unexpectedly, Molecular Partners can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Molecular Partners will offset losses from the drop in Molecular Partners' long position.| Zura Bio vs. Volaris | Zura Bio vs. Western Acquisition Ventures | Zura Bio vs. SFL Corporation | Zura Bio vs. Mesa Air Group |
| Molecular Partners vs. ZyVersa Therapeutics | Molecular Partners vs. Sonnet Biotherapeutics Holdings | Molecular Partners vs. Zura Bio Limited | Molecular Partners vs. Phio Pharmaceuticals Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |